enVVeno Medical Corporation – NASDAQ:HJLI
enVVeno Medical stock price today
$10.38
+5.29
+103.93%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 5 hours
enVVeno Medical stock price monthly change
-50.96%
month
enVVeno Medical stock price quarterly change
-50.96%
quarter
enVVeno Medical stock price yearly change
-18.30%
year
enVVeno Medical key metrics
Market Cap | 98.31M |
Enterprise value | 48.03M |
P/E | -12.39 |
EV/Sales | 11297442228806.45 |
EV/EBITDA | -7.14 |
Price/Sales | 20778456863650.27 |
Price/Book | 2.16 |
PEG ratio | -0.12 |
EPS | -1.75 |
Revenue | N/A |
EBITDA | -23.99M |
Income | -22.11M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -167571325132239.97% |
Oper. margin | -167346738089766.34% |
Gross margin | 100% |
EBIT margin | -167346738089766.34% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeenVVeno Medical stock price history
enVVeno Medical stock forecast
enVVeno Medical financial statements
| Jun 2023 | 0 | -6.47M | |
|---|---|---|---|
| Sep 2023 | 0 | -5.00M | |
| Dec 2023 | 824K | -5.64M | -685.56% |
| Mar 2024 | 0 | -4.99M |
| 2021-03-31 | -0.98 | -2.46 |
|---|---|---|
| 2021-05-12 | -0.34 | -0.48 |
| Jun 2023 | 32086000 | 3.27M | 10.2% |
|---|---|---|---|
| Sep 2023 | 28094000 | 3.17M | 11.32% |
| Dec 2023 | 48635000 | 2.43M | 5.01% |
| Mar 2024 | 44829000 | 2.46M | 5.49% |
| Jun 2023 | -4.56M | 7.00M | 0 |
|---|---|---|---|
| Sep 2023 | -4.21M | 4.44M | 0 |
| Dec 2023 | -4.97M | -22.14M | 25.79M |
| Mar 2024 | -3.54M | 2.19M | 46K |
enVVeno Medical alternative data
| Aug 2023 | 19 |
|---|---|
| Sep 2023 | 19 |
| Oct 2023 | 19 |
| Nov 2023 | 19 |
| Dec 2023 | 19 |
| Jan 2024 | 19 |
| Feb 2024 | 19 |
| Mar 2024 | 19 |
| Apr 2024 | 19 |
| May 2024 | 19 |
| Jun 2024 | 19 |
| Jul 2024 | 19 |
enVVeno Medical other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2021 | 14092 | 0 |
| Jun 2021 | 2000 | 0 |
| Aug 2021 | 1300 | 0 |
| Patent |
|---|
Application Filling date: 18 May 2021 Issue date: 2 Sep 2021 |
Application Filling date: 24 Feb 2021 Issue date: 17 Jun 2021 |
Application Filling date: 10 Mar 2020 Issue date: 20 May 2021 |
Grant Utility: Implantable vein frame Filling date: 14 Nov 2017 Issue date: 30 Mar 2021 |
Grant Filling date: 1 Feb 2016 Issue date: 10 Mar 2020 |
Friday, 24 September 2021 | ||
| Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann | Accesswire | |
Wednesday, 22 September 2021 | ||
| Hancock Jaffe To Rebrand As enVVeno Medical | Benzinga | |
Wednesday, 15 September 2021 | ||
| Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021 | Accesswire | |
Wednesday, 8 September 2021 | ||
| Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics | Seeking Alpha | |
Tuesday, 7 September 2021 | ||
| Hancock Jaffe Laboratories Announces $20 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules | Accesswire | |
Thursday, 19 August 2021 | ||
| Hancock Jaffe Highlights Two-Year Data For Venous Insufficiency Valve | Benzinga | |
| Hancock Jaffe Presents New Positive Two-Year VenoValve Data at the Society for Vascular Surgery Annual Meeting | Accesswire |
-
What's the price of enVVeno Medical stock today?
One share of enVVeno Medical stock can currently be purchased for approximately $10.38.
-
When is enVVeno Medical's next earnings date?
Unfortunately, enVVeno Medical's (HJLI) next earnings date is currently unknown.
-
Does enVVeno Medical pay dividends?
No, enVVeno Medical does not pay dividends.
-
How much money does enVVeno Medical make?
enVVeno Medical has a market capitalization of 98.31M. enVVeno Medical made a loss 23.52M US dollars in net income (profit) last year or -$0.48 on an earnings per share basis.
-
What is enVVeno Medical's stock symbol?
enVVeno Medical Corporation is traded on the NASDAQ under the ticker symbol "HJLI".
-
What is enVVeno Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of enVVeno Medical?
Shares of enVVeno Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does enVVeno Medical have?
As Jul 2024, enVVeno Medical employs 19 workers.
-
When enVVeno Medical went public?
enVVeno Medical Corporation is publicly traded company for more then 7 years since IPO on 31 May 2018.
-
What is enVVeno Medical's official website?
The official website for enVVeno Medical is hancockjaffe.com.
-
Where are enVVeno Medical's headquarters?
enVVeno Medical is headquartered at 70 Doppler, Irvine, CALIFORNIA.
-
How can i contact enVVeno Medical?
enVVeno Medical's mailing address is 70 Doppler, Irvine, CALIFORNIA and company can be reached via phone at +1 949 261 2900.
enVVeno Medical company profile:
enVVeno Medical Corporation
hancockjaffe.comExchange:
NASDAQ
Full time employees:
19
Industry:
Medical - Devices
Sector:
Healthcare
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.
70 Doppler
Irvine, CALIFORNIA 92618
Irvine, CALIFORNIA 92618
CIK: 0001661053
ISIN: US41015N1063
CUSIP: 41015N106
